Last week, the U.S. Centers for Disease Control and Prevention changed the language on a vaccine safety webpage, appearing to legitimize the long-disproven link between childhood vaccines and autism. The switch has sparked confusion among parents, as ...

Bowie reports on Sweden’s plans to introduce autism and attention deficit/hyperactivity disorder (ADHD) de-diagnosing services, asking whether the US and UK might follow suit.1 The proposal raises pressing questions about the nature of diagnosis itself and how societies define,

Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine through its subsidiary Adia Med, today announced that its patent-pending clinical study targeting Autism Spectrum Disorder (ASD) has gone live on ClinicalTrials.